EDA2R and diabetic kidney disease: This study extends our knowledge about the transcription regulation of EDA2R signaling by circRNA, suggesting that targeted inhibition of circHIPK3-mediated EDA2R signaling may provide a novel approach for the treatment of DKD podocyte injury.